| Year |
Citation |
Score |
| 2015 |
Miki H, Takagi M. Design of serum-free medium for suspension culture of CHO cells on the basis of general commercial media. Cytotechnology. 67: 689-97. PMID 25149286 DOI: 10.1007/s10616-014-9778-0 |
0.35 |
|
| 2013 |
Terashima M, Fukukita A, Kodama R, Miki H, Suzuki M, Ikegami M, Tamura N, Yasuda A, Morikawa M, Matsumura S. Evaluation of antioxidant activity of leafy vegetables and beans with myoglobin method. Plant Cell Reports. 32: 349-57. PMID 23160640 DOI: 10.1007/s00299-012-1368-z |
0.328 |
|
| 2012 |
Ikegame A, Ozaki S, Tsuji D, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Watanabe K, Hiasa M, Kimura N, Kikuchi Y, et al. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors. Leukemia. 26: 2124-34. PMID 22430632 DOI: 10.1038/leu.2012.78 |
0.374 |
|
| 2012 |
Yamaoka M, Hara T, Hitaka T, Kaku T, Takeuchi T, Takahashi J, Asahi S, Miki H, Tasaka A, Kusaka M. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. The Journal of Steroid Biochemistry and Molecular Biology. 129: 115-28. PMID 22249003 DOI: 10.1016/j.jsbmb.2012.01.001 |
0.309 |
|
| 2006 |
Ishimoto O, Sugawara S, Inoue A, Ishida T, Munakata M, Koinumaru S, Hasegawa Y, Suzuki T, Miki H, Saijo Y, Nukiwa T. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 1: 979-83. PMID 17409982 |
0.331 |
|
| Show low-probability matches. |